Michael Barbella, Managing Editor03.23.24
It wasn't too difficult to score significant pageviews on ODT's website this past week. On the contrary—it was extremely easy.
An in-depth look at the global orthopedic extremities market was the top traffic driver of the past seven days. The feature explored the trends and technologies shaping the global extremities sector, highlighting the latest advancements from such implant manufacturers as Exactech, Smith+Nephew, Zimmer Biomet, Orthofix Medical, Stryker Corp., Paragon 28, and DePuy Synthes. "Thanks to expanding technologies like robotics, navigation, and MR [mixed reality] solutions, patients will eventually have more options to receive the highest quality care possible," Nnamdi Njoku, president of Sports Medicine, Surgical, Upper Extremities & Restorative Therapies at Zimmer Biomet, told ODT.
Breakthrough Device Designations garnered extremely high pageviews as well this past week, thanks to Bioretec and Osteal Therapeutics. Both companies earned the achievement from the FDA for their RemeOs Spinal Interbody Cage implant and VT-X7, respectively. RemeOs Spinal Interbody Cages are used to restore intervertebral height and facilitate intervertebral body fusion in the cervical spine, while Osteal Therapeutics' VT-X7 is an investigational drug therapy for periprosthetic joint infection (PJI) in the hip and knee. The FDA previously granted VT-X7 Orphan Drug, Qualified Infectious Disease Product, and Fast Track designations.
Another item of extreme interest to ODT loyalists was the first total knee arthroplasty (TKA) using PolarisAR's Stellar Knee mixed-reality surgical guidance system. Stellar Knee guides TKA procedures by showing measured and computer data overlaid directly in a 3D environment. The mixed-reality systems acts as a spatial computer, creating continuous data exchange between the surgeon and software to boost surgical decision-making while simplifying OR workflow, according to the company.
An in-depth look at the global orthopedic extremities market was the top traffic driver of the past seven days. The feature explored the trends and technologies shaping the global extremities sector, highlighting the latest advancements from such implant manufacturers as Exactech, Smith+Nephew, Zimmer Biomet, Orthofix Medical, Stryker Corp., Paragon 28, and DePuy Synthes. "Thanks to expanding technologies like robotics, navigation, and MR [mixed reality] solutions, patients will eventually have more options to receive the highest quality care possible," Nnamdi Njoku, president of Sports Medicine, Surgical, Upper Extremities & Restorative Therapies at Zimmer Biomet, told ODT.
Breakthrough Device Designations garnered extremely high pageviews as well this past week, thanks to Bioretec and Osteal Therapeutics. Both companies earned the achievement from the FDA for their RemeOs Spinal Interbody Cage implant and VT-X7, respectively. RemeOs Spinal Interbody Cages are used to restore intervertebral height and facilitate intervertebral body fusion in the cervical spine, while Osteal Therapeutics' VT-X7 is an investigational drug therapy for periprosthetic joint infection (PJI) in the hip and knee. The FDA previously granted VT-X7 Orphan Drug, Qualified Infectious Disease Product, and Fast Track designations.
Another item of extreme interest to ODT loyalists was the first total knee arthroplasty (TKA) using PolarisAR's Stellar Knee mixed-reality surgical guidance system. Stellar Knee guides TKA procedures by showing measured and computer data overlaid directly in a 3D environment. The mixed-reality systems acts as a spatial computer, creating continuous data exchange between the surgeon and software to boost surgical decision-making while simplifying OR workflow, according to the company.